Skip to content

Opening book details…

About this Medicine article

Stellungnahme der DDG und des BVDD zur EMEA-Empfehlung über das Ruhen der Zulassung für Raptiva® (Efalizumab) by Thomas Luger; Michael Reusch; Kristian Reich; Matthias Augustin; Wolfram Sterry is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Thomas Luger; Michael Reusch; Kristian Reich; Matthias Augustin; Wolfram Sterry
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 1610-0379)
Published
2009
Language
DE
Field
Medicine (Health Sciences)

More by Thomas Luger; Michael Reusch; Kristian Reich; Matthias Augustin; Wolfram Sterry

Browse all works by Thomas Luger; Michael Reusch; Kristian Reich; Matthias Augustin; Wolfram Sterry